In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Prozac; LY-110,140 hydrochloride Drug Master File in Korea (Prozac; LY-110,140 hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Prozac; LY-110,140 hydrochloride. The MFDS reviews the Prozac; LY-110,140 hydrochloride KDMF as part of the drug registration process and uses the information provided in the Prozac; LY-110,140 hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Prozac; LY-110,140 hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Prozac; LY-110,140 hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Prozac; LY-110,140 hydrochloride suppliers with KDMF on PharmaCompass.